We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma.
- Authors
McCarthy, Patrick M; Rendo, Matthew J; Uy, Matthew D; Adams, Alexandra M; O'Shea, Anne E; Nelson, Daniel William; Fenderson, Joshua L; Cebe, Katherine M; Krell, Robert W; Clifton, Guy T; Peoples, George E; Vreeland, Timothy J
- Abstract
Pancreatic ductal adenocarcinoma (PDAC) remains deadly despite advances in systemic therapies and surgical techniques. While there is increasing utilization of immune therapies across diverse cancer types, PDAC remains generally resistant to these treatments. We report a case of locally advanced PDAC treated with preoperative radiation and anti-PD-1 immunotherapy guided by preoperative PD-L1 tumor analysis. After 4 months of preoperative therapy, the patient was submitted to resection, demonstrating a near-complete pathologic response on final tumor analysis. We will discuss the relevant literature and current state of immunotherapeutics for PDAC.
- Subjects
PROGRAMMED cell death 1 receptors; PANCREATIC tumors; ADENOCARCINOMA; RADIOTHERAPY; PROGRAMMED death-ligand 1; IMMUNE checkpoint inhibitors
- Publication
OncoTargets & Therapy, 2021, Vol 14, p3537
- ISSN
1178-6930
- Publication type
Article
- DOI
10.2147/OTT.S311661